P78536 (ADA17_HUMAN) Homo sapiens (Human)

Disintegrin and metalloproteinase domain-containing protein 17 UniProtKBInterProSTRINGInteractive Modelling

824 aa; Sequence (Fasta) ; (Isoform 2; ) Identical sequences: Homo sapiens: B2RNB2; Pan troglodytes: A0A2J8NM15; Pan paniscus: A0A2R9BL62

Molecule Processing
Disintegrin and metalloproteinase domain-containing protein 17

Sequence Features

 406
 184Zinc; in inhibited form
 405Zinc; catalytic
 409Zinc; catalytic
 415Zinc; catalytic
 162K -> E (in dbSNP:rs34431503) VAR_051586 dbSNP
 202R -> G (in dbSNP:rs2230818) VAR_051587 dbSNP
 672-692Helical
 225-333
 365-469
 423-453
 534-555
 573-582
 578-591
 593-600
 48-167Peptidase M12B, propeptide
IPR002870PF01562
 484-557Disintegrin domain
IPR001762PF00200
 581-642ADAM17, membrane-proximal domain
IPR032029PF16698

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRangeDownloadAssess
Crystal structure of the TACE-N-TIMP-3 complex Heteromer
P35625;
ZN;NA;3cki219-474
Crystal structure analysis 0f the TNF-a Coverting Enzyme (TACE) in complexed with Aryl-sulfonamidemonomer ZN;283;2oi0216-477
Crystal structure of TACE in complex with IK682monomer ZN;541;2fv5216-475
Crystal structure of catalytic domain of TACE with the first hydantoin inhibitor occupying the S1' …monomer ZN;724;3l0v216-474
Novel thio-based TACE inhibitors Part 2: Rational design, synthesis and SAR of thiol-contaning aryl…monomer ZN;440;3b92216-474
Crystal structure of catalytic domain of TNF-alpha converting enzyme (TACE) with inhibitormonomer ZN;IH6;1zxc217-475
Crystal structure of catalytic domain of TACE with Thiomorpholine Sulfonamide Hydroxamate inhibitormonomer ZN;4NH;2a8h217-475
Crystal structure of catalytic domain of TACE with carboxylate inhibitormonomer ZN;INN;3ewj218-475
Crystal structure of catalytic domain of TACE with 2-(2-Aminothiazol-4-yl)pyrrolidine-Based Tartrat…monomer IPA;INN;ZN;CA;3o64217-474
Crystal structure of catalytic domain of TACE with hydroxamate inhibitormonomer ZN;INN;CIT;3edz218-475
Crystal structure of the catalytic domain of TACE with Isoindolinone-biphenyl-hydantoin inhibitormonomer Z93;ZN;3lea217-474
Crystal structure of TACE in complex with JMV 390-1monomer ZN;INN;2fv9218-475
Crystal structure of TACE in complex with TAPI-2monomer ZN;CA;INN;IPA;2ddf218-474
Crystal structure of catalytic domain of TACE with tartrate-based inhibitormonomer ZN;INN;3kmc218-474
Crystal structure of the catalytic domain of TACE with Indazolinone-phenyl-hydantoin inhibitormonomer ZN;727;IPA;3le9218-474
Crystal structure of catalytic domain of TACE with phenyl-pyrrolidinyl-tartrate inhibitormonomer ZN;INN;IPA;3kme218-474
Crystal structure of catalytic domain of tace with benzimidazolyl-thienyl-tartrate based inhibitormonomer ZN;50X;3lgp218-474
Crystal structure of catalytic domain of TACE with hydroxamate inhibitormonomer ZN;615;INN;3e8r218-474
Crystal structure of catalytic domain of TACE with hydantoin inhibitormonomer ZN;INN;IPA;3l0t218-474
Crystal structure of catalytic domain of TACE with inhibitormonomer ZN;INN;2i47220-474
CATALYTIC DOMAIN OF TNF-ALPHA CONVERTING ENZYME (TACE)monomer ZN;INN;1bkc219-473
Crystal Structure of TACE with Tryptophan Sulfonamide Derivative Inhibitormonomer 792;ZN;3g42221-474
The membran-proximal domain of ADAM17monomer 2m2f581-642

Homology models

Oligo-stateLigandsQMEANTemplateRangeSeq id (%)DownloadAssess
monomer -3.316be6.4.A221-649
35.06

Homology models built on isoform sequence

Isoform #Oligo-stateLigandsQMEANTemplateRangeSeq id (%)ReportDownloadAssess
2monomerZN;-3.496bdz.1.C223-643
34.74